Table 1.
Clinical characteristics between CALUhigh and CALUlow groups of TCGA BLCA cohort.
| Characteristics | CALU High | CALU Low | P_value |
|---|---|---|---|
| Alive | 94 (46.0%) | 135 (66.2%) | |
| Dead | 110 (54.0%) | 69 (33.8%) | p<0.001 |
| FEMALE | 55 (27.0%) | 52 (25.5%) | |
| MALE | 149 (73.0%) | 152 (74.5%) | 0.822 |
| T1 | 5 (2.5%) | 6 (3.0%) | |
| T2 | 79 (39.1%) | 112 (56.0%) | |
| T3 | 94 (46.5%) | 63 (31.5%) | |
| T4 | 24 (11.9%) | 19 (9.5%) | 0.005 |
| N0 | 107 (57.8%) | 130 (71.8%) | |
| N1 | 30 (16.2%) | 16 (8.8%) | |
| N2 | 41 (22.2%) | 34 (18.8%) | |
| N3 | 7 (3.8%) | 1 (0.6%) | 0.008 |
| M0 | 81 (91%) | 115 (97.5%) | |
| M1 | 8 (9.0%) | 3 (2.5%) | 0.059 |
| Stage I | 1 (0.5%) | 1 (0.5%) | |
| Stage II | 46 (22.7%) | 84 (41.4%) | |
| Stage III | 76 (37.4%) | 64 (31.5%) | |
| Stage IV | 80 (39.4%) | 54 (26.6%) | p<0.001 |
| High Grade | 202 (99.5%) | 182 (90.0%) | |
| Low Grade | 1 (0.5%) | 20 (10.0%) | p<0.001 |
The chi-square and Fisher exact test indicated significant correlation between CALU and survival status(p<0.001), grade (p<0.001), stage (p<0.001), T (p=0.005) and N (p=0.008) classification in BLCA.